About Avience Biomedicals Ltd
Avience Biomedicals is a medical consumable company dedicated to manufacturing of Vitro-Diagnostic (IVD) products and medical devices in Noida, Uttar Pradesh, India.
Founded
2019
CEO
Dharam Deo Choudhary
Employees
65
HQ
Delhi, Delhi
Finished Products
1Regents and lap consumable-tra
₹13.34Cr2Sale of Traded Goods
₹12.94Cr3Instrument-traded
₹7.55Cr4Regents and lapConsumable
₹4.76Cr5Sale of Manufactured Goods
₹3.32Cr6Rapid Cards
₹2.30Cr7Instrument
₹0.63Cr1–7 of 9
Raw Materials
1Purchases of Stock-in-Trade
₹26.31Cr2Cost of Materials Consumed
₹5.58CrAbout Avience Biomedicals Ltd
Avience Biomedicals is a medical consumable company dedicated to manufacturing of Vitro-Diagnostic (IVD) products and medical devices in Noida, Uttar Pradesh, India.
Founded:2019
CEO:Dharam Deo Choudhary
Employees:65
HQ:Delhi, Delhi
Finished Products
1Regents and lap consumable-tra
₹13.34Cr2Sale of Traded Goods
₹12.94Cr3Instrument-traded
₹7.55Cr4Regents and lapConsumable
₹4.76Cr5Sale of Manufactured Goods
₹3.32Cr6Rapid Cards
₹2.30Cr7Instrument
₹0.63Cr1–7 of 9
Raw Materials
1Purchases of Stock-in-Trade
₹26.31Cr2Cost of Materials Consumed
₹5.58CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹415
52W Low
₹222
Volume9.00K
Avg VolumeN/A
BetaN/A
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
22.39x
Valuation
P/B Ratio
1.75x
Valuation
EPS
₹12.28
Valuation
Dividend Yield
0.00%
Valuation
ROE
24.81%
Profitability
ROCE
21.88%
Profitability
Revenue by Segment
Contribution & growth by business line
No segment revenue data available
Geographical Revenue Split
Domestic vs international exposure
Domestic
0.0%
International
0.0%
No geographic split data available
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.70x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
38.3%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.